torsdag den 27. juli 2017

Why these 2 shares could be unlikely recovery plays

Follow this link if this email is not displaying correctly
DAILY BULLETIN
Thursday 27 July 2017
Why these 2 shares could be unlikely recovery plays
by Robert Stephens | Equities | 2 mins. to read
Recovery Stocks
The quad play sector has thus far been a mixed bag for TMT operators. While it was seen as a means of diversifying into new product areas and generating additional sales from cross-selling opportunities, for BT (LON:BT.A) and Talktalk (LON:TALK) it has been a different story.

Both companies have lagged the FTSE 100 over the last year by around 25-30%, with internal challenges meaning their near-term outlooks are relatively downbeat. However, with low valuations, sound strategies and income potential, both companies could offer recovery prospects in the long run.

 
Click here to read the full story
LATEST STORIES FROM OUR BLOG

BooksThe wisdom in books

by Tim Price | Economics | 1 mins. to read
Perhaps the most remarkable thing about Berkshire Hathaway is not the extraordinary wealth that the business has created for its shareholders, although those fortunes are certainly remarkable. What is perhaps most impressive about Warren Buffett and his right-hand man, Charlie Munger, is that they have made no secret about what they do and why they do it.
 
Click here to read the full story

EvilAn altogether different proposition

by Evil Diaries | Evil Diaries | 2 mins. to read
Acacia (LON:ACA) is down again this morning on the supposed news that ACA has been fined $190bn for tax evasion in Tanzania. This compare with ACA's capitalisation at well under $1bn. However, I have read that, possibly, the RNS is incorrect in that the fine is in fact in Tanzanian shillings.
 
Click here to read the full story
QUOTE OF THE DAY

"Random chance plays a huge part in everybody's life."
                                              Gary Gygax
MASTER INVESTOR SHOW VIDEO EXCLUSIVE
Aviation
LATEST EDITION OUT NOW

The Aviation Revolution - And How To Profit From It
  • Jim Mellon - The Master Investor sounds the black swan alert
  • Neil Woodford - Was the star manager right to sell Glaxo and hold AstraZeneca?
  • Private equity renaissance - Why investors are flocking back to this exciting asset class
  • Fantastic Fundraisers - Profit from freshly funded small cap stars
Click here to download as PDF
 
Click here to read online
 
Master Investor Magazine
Master Investor Ltd.
Suite 88, 22 Notting Hill Gate
London, W11 3JE

T: +44 7515 542707
E: swen@masterinvestor.co.uk
Share the newsletter:
Follow us:
Copyright © 2017 Master Investor Ltd, All rights reserved.
Master Investor is a trading name of Master Investor Ltd.

Material contained within Master Investor Magazine and its website is for general information purposes only and is not intended to be relied upon by individual readers in making (or refraining from making) any specific investment decisions. Master Investor Ltd. does not accept any liability for any losses suffered by any user as a result or any such decision.

If a Daily Bulletin is too frequent, why not opt in to our once weekly mailing list
for a round up of the week's news.

Want to change how you receive these emails?
Why did I get this | Unsubscribe from this list | Update subscription preferences

Ingen kommentarer:

Send en kommentar